Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation

Nephrology Dialysis Transplantation

Volumn 25, Issue 1, 2010, Pages 25-31

  Ponticelli, Claudio ^a  

^a Istituto Scientifico Humanitas   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETANERCEPT; GALACTOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLIXIMAB; LF 150195; PODOCIN; RITUXIMAB; STEROID; UNCLASSIFIED DRUG;

CLINICAL FEATURE; DISEASE COURSE; ELECTRON MICROSCOPY; ETHNICITY; FOCAL GLOMERULOSCLEROSIS; GRAFT SURVIVAL; HEPATITIS B; HEREDITY; HUMAN; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MOUSE; MUTATION; NEPHRECTOMY; NEPHROTIC SYNDROME; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RECURRENT DISEASE; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR;

GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY TRANSPLANTATION; PLASMAPHERESIS; PROGNOSIS; RECURRENCE; RISK FACTORS;

EID: 72949091218     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp538     Document Type: Review

References (81)

1. Couser W. Recurrent glomerulonephritis in the renal allograft: an update of selected areas. Exp Clin Transplant 2005; 3: 283-288
2. Newstead CG. Recurrent disease in renal transplants. Nephrol Dial Transplant 2003; 18: 68-74
3. Senggutuvan P, Cameron JS, Hartley RB et al. Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol 1990; 4: 21-28
4. Tejani A, Stablein DH. Recurrence of focal segmental glomerulo-sclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 1992; 2: S258-S263
5. Hickson LJ, Gera M, Amer H et al.Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and responsetotherapy for recurrence. Transplantation 2009; 87: 1232-1239
6. Weber S, Tönshoff B. Recurrence of focal-segmental glomeruloscle-rosis in children after renal transplantation: clinical and genetic aspects. Transplantation 2005; 80: S128-S134
7. Choi KH, Kim SI, Yoon SY et al. Long-term outcome of kidney transplantation in adult recipients with focal segmental glomerulosclerosis. Yonsei Med J 2001; 42: 209-214
8. Dall'Amico R, Ghiggeri G, Carraro M et al. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 1999; 34: 1048-1055
9. Sener A, Bella AJ, Nguan C et al. Focal segmental glomerular sclerosis in renal transplant recipients: predicting early disease recurrence may prolong allograft function. Clin Transplant 2009; 23: 96-100
10. Banfi G, Colturi C, Montagnino G et al. The recurrence of focal segmental glomerulosclerosis in kidney transplant patients treated with cyclosporine. Transplantation 1990; 50: 594-596
11. Abbott KC, Sawyers ES, Oliver JD III et al. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 2001; 37: 366-373
12. Weber S, Gribouval O, Esquivel EL et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 2004; 66: 571-579
13. Vincenti F, Ghiggeri GM. New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. Am J Transplant 2005; 5: 1179-1185
14. Bertelli R, Ginevri F, Caridi G et al. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 2003; 41: 1314-1321
15. Baum MA, Stablein DM, Panzarino VM et al. Loss of living donor renal allograft advantage in children with focal segmental glomeru-losclerosis. Kidney Int 2001; 59: 328-333
16. Cibrik DM, Kaplan B, Campbell DA et al. Renal allograft survival in transplant recipients with focal segmental glomerulosclerosis. Am J Transplant 2003; 3: 64-67
17. Cochat P, Schell M, Ranchin B et al. Management of recurrent nephrotic syndrome after kidney transplantation in children. Clin Nephrol 1996; 46: 17-20 (Pubitemid 26237702)
18. Stokes MB, De Palma J. Post-transplantation nephrotic syndrome. Kidney Int 2006; 69: 1088-1091
19. Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974; 2: 556-560
20. Savin VJ, Sharma R, Sharma M et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996; 334: 878-883
21. Dantal J, Godfrin Y, Koll R et al. Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome. J Am Soc Nephrol 1998; 9: 1709-1715
22. Rea R, Smith C, Sandhu K et al. Successful transplant of a kidney with focal segmental glomerulosclerosis. Nephrol Dial Transplant 2001; 16: 416-417
23. Savin VJ, McCarthy ET, Sharma M. Permeability factors in focal segmental glomerulosclerosis. Semin Nephrol 2003; 23: 147-160
24. Carraro M, Caridi G, Bruschi M et al. Serum glomerular permeability activity in patients with podocin mutation (NPHS2) and steroid resistant nephritic syndrome. J Am Soc Nephrol 2002; 13: 1946-1952
25. Trachtman H, Greenbaum LA, McCarthy ETet al. Glomerular permeability activity: prevalence and prognostic value in pediatric patients with idiopathic nephrotic syndrome. Am J Kidney Dis 2004; 44: 604-610
26. Reiser J, von Gersdorff G, Loos M et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004; 113: 1390-1397
27. Musante L, Candiano G, Bruschi M et al. Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idio-pathic nephrotic syndrome. Clin Exp Immunol 2005; 141: 491-499
28. Charba DS, Wiggins RC, Goyal M et al. Antibodies to protein tyrosine phosphatase receptor type O (PTPro) increase glomerular albumin permeability (Palb). Am J Physiol Renal Physiol 2009; 297: F138-F144
29. Bruneau S, Le Berre L, Hervé C et al. Potential Role of Soluble ST2 Protein in Idiopathic Nephrotic Syndrome Recurrence Following Kidney Transplantation. Am J Kidney Dis (9 June 2009, Epub ahead of print)
30. Le Berre L, Bruneau S, Naulet J et al. Induction of T regulatory cells attenuates idiopathic nephrotic syndrome. J Am Soc Nephrol 2009; 20: 57-67
31. Fine RN. Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children. Pe-diatr Nephrol 2007; 22: 496-502
32. Baum MA. Outcomes after renal transplantation for FSGS in children. Pediatr Transplant 2004; 8: 329-333
33. Pardon A, Audard V, Caillard S et al. Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant 2006; 21: 1053-1059
34. Ehrich JH, Rizzoni G, Brunner FP et al. Combined report on regular dialysis and transplantation of children in Europe, 1989. Nephrol Dial Transplant 1991; 6: 37-47
35. Hariharan S, Adams MB, Brennan DC et al. Recurrent and de novo glomerular disease after renal transplantation. A Report from the Renal Allograft Disease Registry. (RADR) Transplantation 1999; 68: 635-641 (Pubitemid 29453439)
36. Swaminathan S, Lager DJ, Qian X et al.Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants. Nephrol Dial Transplant 2006; 21: 2607-2614
37. Stokes MB, Davis CL, Alpers CE. Collapsing glomerulopathy in renal allografts: a morphological pattern with diverse clinicopathologic associations. Am J Kidney Dis 1999; 33: 658-666
38. Montagnino G, Colturi C, Banfi G et al. Membranous nephropathy in cyclosporine-treated renal transplant patients. Transplantation 1989; 47: 725-727
39. Ingulli E, Tejani A. Incidence, treatment and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children: a single center experience. Transplantation 1991; 51: 401-405
40. Salomon R, Gagnadoux MF, Niaudet P. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after transplantation in children. Transplantation 2003; 75: 810-814
41. Raafat RH, Kalia A, Travis LB et al. High-dose cyclosporine therapy for recurrent focal segmental glomerulosclerosis in children. Am J Kidney Dis 2004; 44: 50-56
42. Tejani AT, Butt K, Trachtman H et al. Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int 1988; 33: 729-734
43. LeBerreL,Godfrin Y,Perretto Set al.The Buffalo/Mna rat, ananimal model of FSGS recurrence after renal transplantation. Transplant Proc 2001; 33: 3338-3340
44. Faul C, Donnelly M, Merscher-Gomez S et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008; 14: 931-938
45. Artero M, Biava C, Amend W et al. Recurrent focal glomeruloscle-rosis. Natural history and response to therapy. Am J Med 1992; 92: 375-383
46. Requião-Moura LR, Moscoso-Solorzano GT, Franco MF et al. Prognostic factors associated with poor graft outcomes in renal recipients with post-transplant glomerulonephritis. Clin Transplant 2007; 21: 363-370
47. Montagnino G, Tarantino A, Banfi G et al. Double recurrence of FSGS after two renal transplants with complete regression after plasma-pheresis and ACE inhibitors. Transpl Int 2000; 13: 166-168
48. Sharma M, McCarthy ET, Reddy DS et al. 8, 9-Epoxyeicosatrienoic acid protects the glomerular filtration barrier. Prostaglandins Other Lipid Mediat 2009; 89: 43-51
49. Leroy S, Guigonis V, Bruckner D et al. Successful anti-TNFalpha treatment in a child with posttransplant recurrent focal segmental glomerulosclerosis. Am J Transplant 2009; 9: 858-861
50. Ohta T, Kawaguchi H, Hattori M et al. Effect of pre-and postoperative plasmapheresis on posttransplant recurrence of focal segmen-tal glomerulosclerosis in children. Transplantation 2001; 71: 628-633
51. Gohh RY, Yango AF, Morrissey PE et al. Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant 2005; 5: 2907-2912
52. Laufer J, Ettenger RB, Ho WG et al. Plasma exchange for recurrent nephrotic syndrome following renal transplantation. Transplantation 1988; 46: 540-542
53. Kawaguchi H, Hattori M, Ito K et al. Recurrence of focal glomeru-losclerosis of allografts in children: the efficacy of intensive plasma exchange therapy before and after renal transplantation. Transplant Proc 1994; 26: 7-8
54. Mowry J, Marik J, Cohen A et al. Treatment of recurrent focal seg-mental glomerulosclerosis with high-dose cyclosporineA and plasma-pheresis. Transplant Proc 1993; 25: 1345-1346
55. Cochat P, Kassir A, Colon S et al. Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophos-phamide. Pediatr Nephrol 1993; 7: 50-54
56. Cheong HI, Han HW, Park HW et al. Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. Nephrol Dial Transplant 2000; 15: 78-81
57. Saleem MA, Ramanan AV, Rees L. Recurrent focal segmental glomerulosclerosis in grafts treated with plasma exchange and increased immunosuppression. Pediatr Nephrol 2000; 14: 361-364
58. Pradhan M, Petro J, Palmer J et al. Early use of plasmapheresis for recurrent post-transplant FSGS. Pediatr Nephrol 2003; 18: 934-938
59. Häffner K, Zimmerhackl LB, von Schnakenburg C et al. Complete remission of post-transplant FSGS recurrence by long-term plasma-pheresis. Pediatr Nephrol 2005; 20: 994-997
60. Garcia CD, Bittencourt VB, Tumelero A et al. Plasmapheresis for recurrent posttransplant focal segmental glomerulosclerosis. Transplant Proc 2006; 38: 1904-1905
61. Fencl F, Simková E, Vondrák K et al. Recurrence of nephrotic protein-uria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports. Transplant Proc 2007; 39: 3488-3490
62. Mahesh S, Del Rio M, Feuerstein D et al. Demographics and response to therapeutic plasma exchange in pediatric renal transplantation for focal glomerulosclerosis: a single center experience. Pediatr Transplant 2008; 12: 682-688
63. Matalon A, Markowitz GS, Joseph RE et al. Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients. Clin Nephrol 2001; 56: 271-278
64. Moriconi L, Lenti C, Puccini R et al. Proteinuria in focal segmental glomerulosclerosis: role of circulating factors and therapeutic approach. Ren Fail 2001; 23: 533-541
65. Ponticelli C, Campise M, Tarantino A. The different patterns of response to plasmapheresis of recurrent focal and segmental glomeru-losclerosis. Transplant Proc 2002; 34: 3069-3071
66. Deegens JK, Andresdottir MB, Croockewit S et al. Plasma exchange improves graft survival in patients with recurrent focal glomeruloscle-rosis after renal transplant. Transpl Int 2004; 17: 151-157
67. Otsubo S, Tanabe K, Shinmura H et al. Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients. Ther Apher Dial 2004; 8: 299-304
68. Valdivia P, Gonzalez Roncero F, Gentil MA et al. Plasmaphere-sis for the prophylaxis and treatment of recurrent focal segmental glomerulosclerosis following renal transplant. Transplant Proc 2005; 37: 1473-1474
69. Singh D, West K, Kamal K et al. Early recurrence of primary focal segmental glomerulosclerosis in an older cadaveric renal allograft recipient resistant to plasmapheresis. Urology 2006; 67: 200
70. Canaud G, Zuber J, Sberro R et al. Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study. Am J Transplant 2009; 9: 1081-1086
71. Pescovitz MD, Book BK, Sidner RA. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 2006; 354: 1961-1963
72. Apeland T, Hartmann A. Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation. Nephrol Dial Transplant 2008; 23: 2091-2094
73. Meyer TN, Thaiss F, Stahl RA. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Transpl Int 2008; 20: 1066-10671
74. Westphal S, Hansson S, Mjörnstedt L et al. Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab. Transplant Proc 2006; 38: 2659-2660
75. Hristea D, Hadaya K, Marangon N et al. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Transpl Int 2007; 20: 102-105
76. Kamar N, Faguer S, Esposito L et al. Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports. Clin Nephrol 2007; 67: 250-254
77. El-Firjani A, Hoar S, Karpinski J et al. Post-transplant focal segmental glomerulosclerosis refractory to plasmapheresis and rituximab therapy. Nephrol Dial Transplant 2008; 23: 425
78. Strologo L, Guzzo I, Laurenzi C et al. Use of Rituximab in focal glomerulosclerosis relapses after renal transplantation. Transplantation 2009; 88: 417-420
79. Yabu JM, Ho B, Scandling JD et al. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Am J Transplant 2008; 8: 222-227
80. Gossmann J, Scheuermann EH, Kachel HG et al. Reactivation of hepatitis B two years after rituximab therapy in a renal transplant patient with recurrent focal segmental glomerulosclerosis: a note of caution. Clin Transplant 2008; 23: 431-434
81. Savin VJ, McCarthy ET, Sharma R et al. Galactose binds to focal seg-mental glomerulosclerosis permeability factor and inhibits its activity. Transl Res 2008; 151: 288-292